Cardiac toxicity of trastuzumab (Herceptin): Implications for the design of adjuvant trials

• 1 February 2001
• journal article
• review article
• Published by Elsevier in Seminars in Oncology
• Vol. 28, 20-27
• https://doi.org/10.1016/s0093-7754(01)90189-7

Abstract

Keywords

• TRASTUZUMAB
• CARDIAC
• ANTIBODY
• TREATMENT
• HERCEPTIN
• EFFICACY
• SAFETY
• DOXORUBICIN
• PRIOR
• DYSFUNCTION